MDEA: Difference between revisions

>Unity
>Unity
mNo edit summary
Line 122: Line 122:
As with other [[stimulant]]s, the chronic use of MDEA can be considered [[Addiction potential::moderately addictive with a high potential for abuse]] and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and [[withdrawal effects]] may occur if a person suddenly stops their usage.
As with other [[stimulant]]s, the chronic use of MDEA can be considered [[Addiction potential::moderately addictive with a high potential for abuse]] and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and [[withdrawal effects]] may occur if a person suddenly stops their usage.


Tolerance to many of the effects of MDEA develops [[Time to full tolerance::with prolonged and repeated use]]. This results in users having to administer increasingly larger doses to achieve the same effects. After that, it takes about [[Time to half tolerance::1 months]] for the tolerance to be reduced to half and [[Time to zero tolerance::2-3 months]] to be back at baseline (in the absence of further consumption). MDEA presents cross-tolerance with [[Cross-tolerance::all [[dopamine]]rgic and [[serotonin|serotonergic]] [[stimulant]]s and entactogens, meaning that after the consumption of MDEA all [[stimulant]]s will have a reduced effect.
Tolerance to many of the effects of MDEA develops [[Time to full tolerance::with prolonged and repeated use]]. This results in users having to administer increasingly larger doses to achieve the same effects. After that, it takes about [[Time to half tolerance::1 months]] for the tolerance to be reduced to half and [[Time to zero tolerance::2-3 months]] to be back at baseline (in the absence of further consumption). MDEA presents cross-tolerance with [[Cross-tolerance::all [[dopamine]]rgic and [[serotonin|serotonergic]] [[stimulant]]s and entactogens]], meaning that after the consumption of MDEA all of these will have a reduced effect.


===Dangerous interactions===
===Dangerous interactions===
Line 130: Line 130:
*'''[[DangerousInteraction::Stimulants]]''' - The neurotoxic effects of MDEA may be increased when combined with other stimulants.
*'''[[DangerousInteraction::Stimulants]]''' - The neurotoxic effects of MDEA may be increased when combined with other stimulants.
*'''[[DangerousInteraction::Cocaine]]''' - This combination may increase strain on the heart.
*'''[[DangerousInteraction::Cocaine]]''' - This combination may increase strain on the heart.
====[[Serotonin syndrome]] risk====
====[[Serotonin syndrome]] risk====
{{DangerousInteractions/SerotoninSyndrome}}   
{{DangerousInteractions/SerotoninSyndrome}}   
Line 147: Line 148:
*[[Entactogens]]
*[[Entactogens]]
*[[Stimulants]]
*[[Stimulants]]
*[[Phenethylamines]]
*[[Phenethylamine]]
*[[Amphetamines]]
*[[Amphetamines]]
*[[MDMA]]
*[[MDMA]]
*[[MDA]]
*[[MDA]]
*[[MDAI]]
*[[MDAI]]
==External links==
==External links==
*[http://en.wikipedia.org/wiki/MDEA MDEA (Wikipedia)]
*[http://en.wikipedia.org/wiki/MDEA MDEA (Wikipedia)]
Line 162: Line 164:
[[Category:Psychoactive substance]]
[[Category:Psychoactive substance]]
[[Category:Amphetamine]]
[[Category:Amphetamine]]
[[Category:Stimulant]]
[[Category:Phenethylamine]]
[[Category:Entactogen]]
[[Category:Entactogen]]
{{#set:Featured=false}}
{{#set:Featured=false}}
Retrieved from "http://psy.st/wiki/MDEA"